Hims & Hers launched in 2017 with a simple idea: make it easy and stigma-free for people to get treatments for conditions they might feel awkward discussing in person. The company started with men’s health — hair loss and erectile dysfunction — then quickly expanded to women’s health, skincare, and mental health under the “Hers” brand.
The model is straightforward. Customers fill out an online questionnaire, a licensed provider reviews it, and if appropriate, prescriptions get shipped directly to their door. No waiting rooms, no insurance headaches. The company operates its own pharmacy fulfillment network, which gives it tighter control over costs and delivery times.
Hims & Hers went public through a SPAC deal in 2021 and has continued growing rapidly. The platform now offers treatments across more than 30 conditions, including anxiety, depression, weight management, and dermatology. Monthly subscription plans keep pricing predictable, and the company has been expanding into personalized compounded medications. Revenue has grown steadily as the brand has moved well beyond its original niche.
